InMode to Present at March Investor Conferences and Events
YOKNEAM,

Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Presenters:
Format: Virtual fireside chat moderated by
When: Tuesday, March 12 at
A live webcast of the presentation can be accessed here.
2024 Barclays Global Healthcare Conference
Presenters: Yair Malca, Chief Financial Officer, and Dr.
Format: In-person fireside chat moderated by
Where:
When: Wednesday, March 13 at
A live webcast of the presentation can be accessed here.
Jefferies Miami MedTech Doctor Summit
Presenters: Dr.
Format: Aesthetics/Plastic Surgery Panel
Where: Miami, FL
When: Friday, March 15 at
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Investor Relations Contact:
MS-IR LLC
917-607-8654
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-march-investor-conferences-and-events-302074713.html
SOURCE InMode LTD
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BEAR NutriEase Baby Food Maker Stands Out With a Stainless Steel Design in a Plastic-Dominated Category
- Best Crypto To Invest In: Blue Chips Wait for the Next Catalyst While AlphaPepe Builds the Pre-Discovery Trade
- InMode confirms unsolicited acquisition bid from Steel Partners
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Jefferies & Co, BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share